Welcome to My Blog
Here is a masonry blog layout with no sidebarTrump’s description of India as filthy sets off calls for cleaner air
Monsanto loses final appeal over French farmer’s weedkiller accident
AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same
AstraZeneca said that it is not unusual for some trial participants to fall ill during large scale vaccine trials but that the U.S. Food and Drug Administration has reviewed all safety data from the trials globally and deemed it safe to continue testing the vaccine.
AstraZeneca trials in the United Kingdom, Brazil and South Africa resumed last month even as the U.S. Food and Drug Administration continued its investigation into the case.
NGT slams Centre over inadequate measures to prevent wastage of groundwater
“Overriding environmental law principle of ‘Polluter Pays’ must be invoked by all the regulators to ensure that wastage of water is not profitable and cost of such wastage is recovered which is necessary for restoration of the environment without merely limiting to statutory changes which are no substitute to ‘Polluter Pays’ principle,” the bench said.
COVID-19: India records 54,366 new infections, 690 deaths
A total of 69,48,497 people have recuperated from the disease so far pushing the national recovery rate to 89.53 per cent while the case fatality rate due to COVID-19 was recorded at 1.51 per cent.
According to the Indian Council of Medical Research (ICMR), a cumulative total of 10,01,13,085 samples have been tested up to October 22 with 14,42,722 samples being tested on Thursday.
Next 3 months decisive in determining Covid situation: Harsh Vardhan
Addressing a review meeting with officials of the Uttar Pradesh government, Vardhan said, “Appropriate measures are being taken to combat COVID-19. But the next three months are going to be decisive in determining the situation of COVID in the country. If we take adequate precaution and follow COVID-appropriate behaviour in the coming festival and winter season, we will be in a better position to fight corona.”
He asserted that the state needs to focus on increasing testing, surveillance, contact tracing, and early diagnosis to keep fatality rate low.
No foolproof anonymity: Justice Srikrishna on data protection
“What is thought to be anonymous can be de-anonymised tomorrow. Therefore, there is no foolproof anonymity. All that law can say is take it as anonymous, if you do de-anonymity, identify the person, then you will be answerable to the law,” Justice Srikrishna said at a FICCI event.
The draft of the personal data protection bill, approved by the Cabinet in December 2019, proposes a penalty of up to Rs 15 crore and up to three-year jail term for company executives for violating privacy norms.
Startups, SMEs most vulnerable in India to cyberattacks: Report
The most common forms of cybersecurity challenges faced by startups are negligence by employees and employee mobility, according to the report.
The most common forms of employee negligence which lead to cyberattacks including data breaches are accidental loss of the device containing confidential data, leaving the workstation unprotected or unattended, sharing confidential information such as passwords via paper notes and remote working using an unsecured or public network connection.
Security researcher breaks into Trump’s Twitter account
Insurers drop appeal against UK COVID-19 payout ruling on three policies
appeals linked to the Resilience, Eaton Gate Retail, and Eaton Gate Pubs & Restaurants policies have now been dropped, legal documents show, raising hopes that hundreds of vulnerable businesses could see their claims processed without further delay.
A spokesman for RSA, one of the largest of the six insurers, said it would work with broker Marsh to make interim payments where appropriate.
Businesses across the world have been locked in disputes with insurance companies over pandemic-related payouts.
COVID-19: India records 55,839 new infections, 702 deaths
The active cases of coronavirus infection remained below eight lakh for the sixth consecutive day
There are 7,15,812 active cases of coronavirus infection in the country which accounts for 9.29 per cent of the total caseload, the data stated
According to the Indian Council of Medical Research (ICMR), a cumulative total of 9,86,70,363 samples have been tested up to October 21, of which 14,69,984 were tested on Wednesday.
Number of South Koreans dying after flu shot rises, prompts vaccine worries
South Korea’s vaccines come from a variety of sources. Manufacturers include local drug makers GC Pharma, SK Bioscience and Ilyang Pharmaceutical Co, along with France’s Sanofi and Britain’s Glaxosmithkline. Distributors include LG Chem Ltd and Boryung Biopharma Co. Ltd., a unit of Boryung Pharm Co. Ltd..GC Pharma, LG Chem, SK Bioscience and Boryung declined to comment. Ilyang Pharmaceutical, Sanofi and GSK could not immediately be reached for comment.
Govt restores all existing visas, barring electronic, tourist and medical categories
Foreign nationals intending to visit India for medical treatment can apply afresh for a medical visa, including for their medical attendants
Therefore, this decision will enable foreign nationals to come to India for various purposes such as business, conferences, employment, studies, research, medical purposes etc
India has set aside $7 billion to vaccinate the world’s second Biggest Population
Prime Minister Narendra Modi’s administration estimates an all-in cost of about $6-$7 per person in the nation of 1.3 billion, the people said, asking not to be identified as the details are private. The money provisioned so far is for the current financial year ending March 31 and there will be no shortage of further funds for this purpose, they added.A Finance Ministry spokesman couldn’t immediately be reached when tried on his mobile.
Doctors in Delhi see jump in breathing issues amid COVID-19, pollution
“Pollutants have an inflammatory effect on the lungs and so does COVID-19,” said Dhiren Gupta, a pulmonologist at Sir Ganga Ram Hospital in the city, which has reported more than 340,000 coronavirus cases.There has not been any study in India to ascertain whether pollution leads to more severe complications among patients infected by the novel coronavirus. But a study by the Harvard T.H. Chan School of Public Health in the United States found here that long-term exposure to fine particulate matter known as PM2.5 increased the risk of death from COVID-19.
India’s Dr Reddy’s isolates data center services after cyberattack
Kotak Life forays into health insurance;launches Kotak Health Shield
G. Murlidhar, MD & CEO, Kotak Mahindra Life Insurance Company Ltd. said, “Rising health treatment costs continues to be a major financial strain to crores of Indians across geographies, and our new Kotak Health Shield is yet another insurance policy from Kotak Life that has been designed to address the much required insurance cover to Indian consumers. Kotak Health Shield is an affordable health insurance policy that covers major critical illnesses.”
Tesla’s release of new ‘self-driving’ software closely watched by U.S. regulato
“NHTSA has been briefed on Tesla’s new feature, which represents an expansion of its existing driver assistance system. The agency will monitor the new technology closely and will not hesitate to take action to protect (the) public against unreasonable risks to safety,” the National Highway Traffic Safety Administration said in a statement.